U

Unicycive Therapeutics
D

UNCY

0.60000
USD
-0.01
(-1.64%)
مغلق
حجم التداول
5,939
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
62,277,844
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Unicycive Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.